IP Library Patent Application 18694164
Patent Application
App. No. 18/694,164

VHH ANTIBODIES TARGETING FIMH AND METHODS OF USING THE SAME

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/694,164
Abstract

One or more antibodies, particularly nanobodies or VHH single domain antibodies, directed against one or more FimH targets with roles in E. coli colonization in animals are provided. The nanobodies are useful in reducing or inhibiting E. coli colonization or infection. Methods of treating and/or preventing E. coli infection and conditions related thereto are provided.

Claims (6)

1 . A polypeptide selective for type 1 fimbriae D-mannose specific adhesin (FimH), wherein said polypeptide comprises a sequence selected from EFH-2D7 (SEQ ID NO:25) and EFH-2E10 (SEQ ID NO:27).

2 . A method for reducing or inhibiting E. coli colonization or infection in a host, comprising administering to said host a composition comprising a polypeptide selective for type 1 fimbriae D-mannose specific adhesin (FimH).

3 . The method according to claim 2 , wherein the polypeptide comprises a sequence selected from EFH-2D7 (SEQ ID NO:25) and EFH-2E10 (SEQ ID NO:27)

4 . The method according to claim 2 , wherein the host suffers from bacterial gastroenteritis, Crohn's Disease, ulcerative colitis and/or urinary tract infections.

5 . A method for enhancing an immune response against E. coli infections in animals, comprising administering to said host a composition comprising a polypeptide selective for type 1 fimbriae D-mannose specific adhesin (FimH).

6 . The method according to claim 5 , wherein the polypeptide comprises a sequence selected from EFH-2D7 (SEQ ID NO::25) and EFH-2E10 (SEQ ID NO::27)

Assignments (1)
ENTITY CONVERSION Recorded Mar 26, 2025
From: BIOMEDIT, LLC
To: BIOMEDIT, INC.
Reel/Frame 070635/0285 →